Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PFDN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EML2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSMAF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLOC1S1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BLVRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NSDHL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SZRD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDK2AP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MRPL23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6778 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBPL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAV2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COX14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LAMTOR4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATP5D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GOLT1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL13AP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on